Disability Expo to host webinar ‘Breaking Barriers: Disability, Sex & Relationships’

Published:

Updated:

Disability Expo esteemed panel of experts are bringing a diverse perspective and shedding light on the challenges, triumphs, and unique experiences faced by individuals with disabilities in navigating their sexual and relational lives this Thursday 25th May at 1pm GMT. From exploring societal stigmas and misconceptions to addressing accessibility barriers and advocating for inclusive policies, they will delve into crucial topics that deserve open and honest conversations.

This event will serve as a platform for engaging dialogue, providing a safe space to discuss the complexities surrounding disability, sexuality, and building meaningful relationships. Attendees will gain valuable insights, practical tips, and a broader understanding of the diverse needs and desires of disabled individuals, as well as strategies for fostering inclusivity and promoting positive change.

Whether you are an individual with a disability, a caregiver, a professional in the field, or simply passionate about creating a more inclusive society, this LinkedIn Live panel discussion is for you. See link below and bio link to speakers.

Speakers are Kelly Gordon the Head of Create and UK/EU at Hot Octopuss who will be at Disability Expo. Her bio is here.

Emi Ainscough is a blogger who has written on Disability and dating her blog can be found here.

Lorraine is the CEO at SWAD (sex with a difference) you can find out more about the organisation here

You can find the webinar here.

Latest Posts

  • Calling on all the community to ACT NOW to avoid losing treatments!

    Calling on all the community to ACT NOW to avoid losing treatments!

    Currently, there are two approved treatments for SMA: risdiplam and nusinersen. These treatments were initially approved temporarily under Managed Access Agreements while the NHS and NICE gathered data to assess their cost-effectiveness. Now, as these agreements come to an end, both treatments face a crucial review.

    Read more

  • NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    SMA UK are proud to join together with Treat SMA and MDUK to bring you this webinar about NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam. 2024 sees the end of the managed access agreements (MAAs) for the two treatments. An expert committee will gather to assess the new clinical and real-world evidence, along…

    Read more

  • Let the battle begin

    Let the battle begin

    This year the Managed Access Agreement for Spinraza and Risdiplam expires. The MAA was put in place five years ago so the pharmaceutical companies could gather more evidence to resubmit to NICE for approval on the NHS with Biogen extending their MAA by a year.

    Read more